1Shinabarger DL,Marotti KR,Merray RW,et al.Mechanism of action of oxazolidinones:effects of linezolid and eperezolid on translation reactions.Antimicrob Agents Chemother,1997,41:2132-2136.
2Noskin GA,Siddiqui F,Stosor V,et al.In vitro activities of linezolid against important Gram-positive bacterial pathogens including vancomycin-resistant enterococci.Antimicrob Agents Chemother,1999,43:2059-2062.
3Bostic GD,Perri MB,Thal LA,et al.Comparative in vitro and bactericidal activity of oxazolinone antibiotics against multid-rug-resistant enterococci.Diagn Microbiol Infect Dis,1998,30:109-112.
4Kaatz GW,Seo SM.In vitro activities of oxazolidinone compo-unds U-100766 against Staphylococcus aureus and Staphylo-coccus epidermidis.Antimicrob Agents Chemother,1996,40:799-801.
5Murry RW,Schaadt RD,Zurenko GE,et al.Ribosomes from an oxazolinone-resistant mutant confer resistance to eperezolid in a Staphylococcus aureus cell-free transcription-translation assay.Antimicrob Agents Chemother,1998,42:947-950.
6Ford CW,Hamel JC,Wilson DM,et al.In vivo activities of U-100592 and U-100766,novel oxazolidinone antimicrobial agents,against experimental bacterial infections.Antimicrob Agents Chemother,1996,40:1508-1513.
7Stalker DJ,Kearns GL,James L,et al.Pharmacokinetics of linezolid in pediatric patients.In:36th Meeting of the tnfectious Diseases Society of America,1998.749.
8Li Z,Willke RJ,Pinto IA,et al.Comarison of length of hospital stay for patients with known suspected methicillin-resistant staphylococcus species infection treated with linezolid or vancomycin:a randomized,multicentre trial.Pharmacother-apy,2001,21:263-274.
